Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Left Stellate Ganglion Block on Systemic Inflammation and Neuromodulation in CABG Surgery

NCT07776496 is registered in ClinicalTrials.gov with OMAR ABDELAZIZ ABOELFADL as lead sponsor.

NCT NCT07776496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07776496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Left Stellate Ganglion Block on Systemic Inflammation and Neuromodulation in CABG Surgery
Lead sponsor
OMAR ABDELAZIZ ABOELFADL
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
August 1, 2028
Enrollment
81 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cabg, delirium - postoperative, inflammation biomarkers, stellate ganglion block